İçeriğe geç
akaturk Akademik ölçüm

Akademisyen

ARZU ZEYNEP KARABAY

PROFESÖR

ANKARA ÜNİVERSİTESİ ECZACILIK FAKÜLTESİ TEMEL ECZACILIK BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Tıbbi Biyokimya

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 57
  • Proje 0
  • Kitap 4
  • Bildiri 30
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 13 Q2 20 Q3 10 Q4 3
WoS (JCR) Q1 8 Q2 6 Q3 20 Q4 8
TR Index 3 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 2
Üst %10 makale 7
Ort. yüzdelik 58.6%
Üst %1 payı 3.9%
Üst %10 payı 13.7%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 57 yayın

Makale listesi

  1. 2026 Synthesis, characterization and biological activity of metal nanoparticles with green method using apple industry waste Nanotechnology Reviews DOI 10.1515/ntrev-2025-0281 YÖKSİS SJR Q1 JCR Q1 OpenAlex 13.2%
  2. 2025 Multifaceted Therapeutic Potential of Plant-Derived Exosomes: Immunomodulation, Anticancer, Anti-Aging, Anti-Melanogenesis, Detoxification, and Drug Delivery Biomolecules DOI 10.3390/biom15030394 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %1 OpenAlex 99.7%
  3. 2025 Targeting Integrin α2 to Overcome Imatinib Resistance in Chronic Myeloid Leukemia Cells Biomolecules DOI 10.3390/biom15091245 YÖKSİS SJR Q1 JCR Q1 OpenAlex 24.3%
  4. 2024 Identification of exosomal microRNAs and related hub genes associated with imatinib resistance in chronic myeloid leukemia Naunyn Schmiedebergs Arch Pharmacol DOI 10.1007/s00210-024-03198-1 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 90.4%
  5. 2024 Methylsulfonylmethane induces caspase-dependent apoptosis in acute myeloid leukemia cell lines Fundam Clin Pharmacol DOI 10.1111/fcp.13030 YÖKSİS SJR Q2 JCR Q3 OpenAlex 84.1%
  6. 2024 Nilotinib exhibits less toxicity than imatinib and influences the immune state by modulating iNOS, p-p38 and p-JNK in LPS/IFN gamma-activated macrophages Toxicology in Vitro DOI 10.1016/j.tiv.2023.105754 YÖKSİS SJR Q2 JCR Q3 OpenAlex 78.9%
  7. 2023 Phenotypic and functional characterization of subpopulation of Imatinib resistant chronic myeloid leukemia cell line Advances in Medical Sciences DOI 10.1016/j.advms.2023.06.002 YÖKSİS SJR Q2 JCR Q3 OpenAlex 74.2%
  8. 2023 Novel indole retinoid derivative induces apoptosis and cell cycle arrest and modulates AKT and ERK signaling in HL‐60 cells Wiley DOI 10.1111/fcp.12876 YÖKSİS SJR Q2 JCR Q3 OpenAlex 44.3%
  9. 2023 KOENZİM Q0 İNSAN KRONİK MYELOİD LÖSEMİ K562 HÜCRELERİNİN PROLİFERASYONUNU ENGELLER VE MAPK VE AKT SİNYAL YOLAKLARINI MODÜLE EDER Ankara Universitesi Eczacilik Fakultesi Dergisi DOI 10.33483/jfpau.1286359 YÖKSİS SJR Q3 OpenAlex 49.9%
  10. 2023 Effects of trazodone on viability in healthy and malignant ovarian cells Aegean Journal of Medical Sciences DOI 10.33713/egetbd.1332111 YÖKSİS OpenAlex 14.2%
  11. 2022 AN INVESTIGATION ON THE EFFECTS OF SIRT5 MODULATORS ON SIRT5 AND CYTOCHROME C PROTEIN EXPRESSIONS IN K562 CHRONIC MYELOID LEUKEMIA CELL LINE Ankara Universitesi Eczacilik Fakultesi Dergisi DOI 10.33483/jfpau.1081893 YÖKSİS SJR Q4 OpenAlex 13.6%
  12. 2022 CYTOTOXIC AND ANTIOXIDANT ACTIVITIES OF ALCHEMILLA MOLLIS (BUSER) ROTHM. AND ITS CONTITUENTS; HYPEROSIDE AND ISOQUERCETIN Ankara Universitesi Eczacilik Fakultesi Dergisi DOI 10.33483/jfpau.991921 YÖKSİS SJR Q4 OpenAlex 31.7%
  13. 2022 Time and Concentration Dependent Effects of Different Solvents on Proliferation of K562, HL60, HCT-116 and H929 Cell Lines Journal of Research in Pharmacy DOI 10.29228/jrp.146 YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 66.0%
  14. 2021 Assessment of azithromycin as an anticancer agent for treatment of imatinib sensitive and resistant CML cells Leukemia Research DOI 10.1016/j.leukres.2021.106523 YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 92.7%
  15. 2021 EFFECTS OF PROBUCOL ON CELL PROLIFERATION IN LEUKEMIA, MULTIPLE MYELOMA, LYMPHOMA AND FIBROBLAST CELL LINES Turkish Journal of Pharmaceutical Sciences DOI 10.4274/tjps.04657 YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 19.1%
  16. 2021 Synthesis and Cytotoxicity of Some Imidazo[4,5-b]pyridine Derivatives and Their Regioselective N-Alkylation ChemistrySelect DOI 10.1002/slct.202004584 YÖKSİS SJR Q2 JCR Q3 OpenAlex 62.0%
  17. 2020 Regioselective N-alkylation of some imidazole-containing heterocycles and their in vitro anticancer evaluation JOURNAL OF MOLECULAR STRUCTURE DOI 10.1016/j.molstruc.2019.127673 YÖKSİS SJR Q2 JCR Q3 OpenAlex 64.7%
  18. 2020 Synthesis of Some Benzimidazole-derived Molecules and their Effects on PARP-1 Activity and MDA-MB-231, MDA-MB-436, MDA-MB-468 Breast Cancer Cell Viability Anti-Cancer Agents in Medicinal Chemistry DOI 10.2174/1871520620666200502001953 YÖKSİS SJR Q3 JCR Q3 OpenAlex 65.4%
  19. 2018 Expression analysis of Akirin-2, NFκB-p65 and β-catenin proteins in imatinib resistance of chronic myeloid leukemia Hematology DOI 10.1080/10245332.2018.1488795 YÖKSİS SJR Q3 JCR Q4 OpenAlex 75.4%
  20. 2018 Apoptotic Effects of Some Tetrahydronaphthalene Derivatives on K562 Human Chronic Myelogenous Leukemia Cell Line Anti-Cancer Agents in Medicinal Chemistry DOI 10.2174/1871521409666170412122811 YÖKSİS SJR Q2 JCR Q3 OpenAlex 56.4%

Akademisyenlere dön